DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Kostine M, Finckh A, Bingham CO. et al.
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Ann Rheum Dis 2020;
DOI: 10.1136/annrheumdis-2020-217139.
We do not assume any responsibility for the contents of the web pages of other providers.